PatientsVille.com Logo

Prophylaxis and Baktar

PatientsVille

Prophylaxis Symptoms and Causes

In the early 1980s, when the HIV/AIDS epidemic began, patients rarely lived longer than a few years. But today, there are many effective medicines to fight the infection, and people with HIV have longer, healthier lives.

There are five major types of medicines:

  • Reverse transcriptase (RT) inhibitors - interfere with a critical step during the HIV life cycle and keep the virus from making copies of itself
  • Protease inhibitors - interfere with a protein that HIV uses to make infectious viral particles
  • Fusion inhibitors - block the virus from entering the body's cells
  • Integrase inhibitors - block an enzyme HIV needs to make copies of itself
  • Multidrug combinations - combine two or more different types of drugs into one

These medicines help people with HIV, but they are not perfect. They do not cure HIV/AIDS. People with HIV infection still have the virus in their bodies. They can still spread HIV to others through unprotected sex and needle sharing, even when they are taking their medicines.

NIH: National Institute of Allergy and Infectious Diseases

Check out the latest treatments for prophylaxis

prophylaxis treatment research studies

Baktar clinical trials, surveys and public health registries


Find Drug Side Effect reports



Baktar Side Effects

Sepsis (4)
Platelet Count Decreased (4)
Pneumonia (4)
Rash (3)
Liver Disorder (3)
Anaemia (2)
Altered State Of Consciousness (2)
Hepatic Function Abnormal (2)
Disseminated Intravascular Coagulation (2)
Renal Failure Acute (2)
Interstitial Lung Disease (2)
Pyrexia (2)
Pancytopenia (2)
Pneumothorax (2)
Neutropenia (2)
Anaplastic Astrocytoma (1)
Anxiety (1)
Respiratory Disorder (1)
Arthritis Infective (1)
Mediastinal Abscess (1)
Lymphoproliferative Disorder (1)
Malaise (1)
Lymphocyte Count Decreased (1)
Pneumonia Aspiration (1)
Pathogen Resistance (1)
Irritability (1)
Prothrombin Time Prolonged (1)
Neoplasm Malignant (1)
Muscular Weakness (1)
Meniscus Lesion (1)
Muscle Spasms (1)
Inguinal Hernia Repair (1)
Asthenia (1)
Acute Graft Versus Host Disease (1)
Accident (1)
Shock (1)
Alanine Aminotransferase Increased (1)
Deep Vein Thrombosis (1)
Staphylococcal Sepsis (1)
Thrombocytopenia (1)
Rheumatoid Arthritis (1)
Respiratory Failure (1)
Haemorrhage (1)
Hallucination, Auditory (1)
Hepatic Failure (1)
Glossitis (1)
Brain Cancer Metastatic (1)
Blood Creatine Phosphokinase Increased (1)
Blood Creatinine Decreased (1)
Hepatitis Acute (1)

➢ More


Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

Prophylaxis Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Recruiting Urinary NGF as A Biomarker for Acute Bacterial Cystitis
Condition: Urinary Tract Infection
Interventions: Drug: Baktar 800mg h.s.;   Drug: Celecoxib 200mg QD
Outcome Measures: Change from Baseline in urinary nerve growth factor (NGF) at different time points;   Change from Baseline in one-day voiding diary at different time points;   Change from Baseline in Overactive Bladder Symptom Score (OABSS) at different time points;   Change from Baseline in visual analog scale of pain (VAS) at different time points